Shankar Reddy Gagginapally

Title: Innovations of Shankar Reddy Gagginapally

Introduction

Shankar Reddy Gagginapally is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of muscarinic M1 receptor positive allosteric modulators. With a total of three patents to his name, Gagginapally's work is paving the way for advancements in medical treatments.

Latest Patents

Gagginapally's latest patents include innovative compounds that serve as muscarinic M1 receptor positive allosteric modulators. The first patent describes compounds of formula (I), or their isotopic forms, stereoisomers, tautomers, or pharmaceutically acceptable salts as M1 PAMs. This invention outlines the preparation, pharmaceutical composition, and use of these compounds. The second patent also focuses on compounds of formula (I), emphasizing their utility in treating various disorders related to the muscarinic M1 receptor. Both patents highlight the methods of preparing such compounds and the pharmaceutical compositions that include them.

Career Highlights

Shankar Reddy Gagginapally is currently associated with Suven Life Sciences Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments that address critical health issues.

Collaborations

Gagginapally collaborates with talented professionals in his field, including Ramakrishna Nirogi and Abdul Rasheed Mohammed. These collaborations enhance the research and development efforts at Suven Life Sciences Limited.

Conclusion

Shankar Reddy Gagginapally's contributions to the field of pharmaceuticals through his innovative patents are noteworthy. His work on muscarinic M1 receptor positive allosteric modulators holds promise for future medical advancements.